IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Dechra Pharma

CUSIP: G2769C145 | 1 institutional holders

Quarters

Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

Boston Common Asset Management, LLC124,831
0.0% of portfolio›$5.8K
StyleTurnoverLocationFiled
Boston Common Asset Management, LLC
124,831$5.8K0.0%CoreLowBoston, MA2023-10-11